Portal de Periódicos da CAPES

Osteopenia in children with acute lymphoblastic leukemia: A pilot study of amelioration with pamidronate

2002; Alan R. Liss, Inc.; Volume: 39; Issue: 1 Linguagem: Inglês

10.1002/mpo.10057

1096-911X

Ronald D. Barr, Chun Guo, John Wiernikowski, Colin E. Webber, Marilyn Wright, Stephanie A. Atkinson,

Blood disorders and treatments

Medical and Pediatric OncologyVolume 39, Issue 1 p. 44-46 Brief Report Osteopenia in children with acute lymphoblastic leukemia: A pilot study of amelioration with pamidronate Ronald D. Barr MB, ChB, MD, Corresponding Author Ronald D. Barr MB, ChB, MD [email protected] Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada Hamilton Health Sciences Corporation, Hamilton, Ontario, CanadaRoom 3N27B, Health Sciences Center, McMaster University, 1200 Main St. West, Hamilton, Ontario, Canada L8N 3Z5.Search for more papers by this authorChun Yuan Guo PhD, Chun Yuan Guo PhD Faculty of Health Sciences, McMaster University, Hamilton, Ontario, CanadaSearch for more papers by this authorJohn Wiernikowski Pharm D, John Wiernikowski Pharm D Hamilton Health Sciences Corporation, Hamilton, Ontario, CanadaSearch for more papers by this authorColin Webber PhD, Colin Webber PhD Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada Hamilton Health Sciences Corporation, Hamilton, Ontario, CanadaSearch for more papers by this authorMarilyn Wright BScPT, MEd, Marilyn Wright BScPT, MEd Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada Hamilton Health Sciences Corporation, Hamilton, Ontario, CanadaSearch for more papers by this authorStephanie Atkinson PhD, Stephanie Atkinson PhD Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada Hamilton Health Sciences Corporation, Hamilton, Ontario, CanadaSearch for more papers by this author Ronald D. Barr MB, ChB, MD, Corresponding Author Ronald D. Barr MB, ChB, MD [email protected] Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada Hamilton Health Sciences Corporation, Hamilton, Ontario, CanadaRoom 3N27B, Health Sciences Center, McMaster University, 1200 Main St. West, Hamilton, Ontario, Canada L8N 3Z5.Search for more papers by this authorChun Yuan Guo PhD, Chun Yuan Guo PhD Faculty of Health Sciences, McMaster University, Hamilton, Ontario, CanadaSearch for more papers by this authorJohn Wiernikowski Pharm D, John Wiernikowski Pharm D Hamilton Health Sciences Corporation, Hamilton, Ontario, CanadaSearch for more papers by this authorColin Webber PhD, Colin Webber PhD Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada Hamilton Health Sciences Corporation, Hamilton, Ontario, CanadaSearch for more papers by this authorMarilyn Wright BScPT, MEd, Marilyn Wright BScPT, MEd Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada Hamilton Health Sciences Corporation, Hamilton, Ontario, CanadaSearch for more papers by this authorStephanie Atkinson PhD, Stephanie Atkinson PhD Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada Hamilton Health Sciences Corporation, Hamilton, Ontario, CanadaSearch for more papers by this author First published: 19 May 2002 https://doi.org/10.1002/mpo.10057Citations: 35AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. REFERENCES 1 Haddy TB, Mosher RB, Reaman GH. Osteoporosis in survivors of acute lymphoblastic leukemia. Oncologist 2001; 6: 278– 285. 2 Halton JM, Atkinson SA, Fraher L, et al. Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia. J Bone Min Res 1996; 11: 1774– 1783. 3 Barr RD, Petrie C, Furlong W, et al. Health-related quality of life during post-induction chemotherapy in children with acute lymphoblastic leukemia in remission: an influence of corticosteroid therapy. Int J Oncol 1997; 11: 333– 339. 4 Hahn TS, Boisseau VC, Aviolo LV. Effect of chronic corticosteroid administration on diaphyseal and metaphyseal bone mass. J Clin Endocrinol Metab 1974; 39: 274– 282. 5 Warner JT, Evans WD, Dunstan FDJ, et al. Relative osteopenia following treatment for childhood acute lymphoblastic leukemia. Med Pediatr Oncol 1996; 27: 241 (abstract 0–119). 6 Hoorweg-Nijman JJG, van Dijk HJ, Pieters R, et al. Bone mineralization after (treatment for) acute lymphoblastic leukemia. Med Pediatr Oncol 1996; 27: 292 (abstract P 20). 7 Shoemaker LR. Expanding role of bisphosphonate therapy in children. J Pediatr 1999; 134: 264– 267. 8 Glorieux F, Bishop NJ, Plotkin H, et al. Cyclic administration of Pamidronate in children with severe osteogenesis imperfecta. N Engl J Med 1998; 339: 947– 952. 9 Smith M, Arthur D, Camitta B, et al. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol 1996; 14: 18– 24. 10 Langman CB, Thorson DK, Shaykin RA, et al. Alendronate therapy in osteopenic pediatric disorders. Bone 1998; 23(Suppl): S457. 11 Kunzman V, Bauer E, Feurle J, et al. Stimulation of γ δ cells by aminobisphosphonate and induction of antiplasma cell activity in multiple myeloma. Blood 2000; 96: 384– 392. Citing Literature Volume39, Issue1July 2002Pages 44-46 ReferencesRelatedInformation